Stay updated on Venetoclax in Myeloma with Bortezomib: Clinical Trial
Sign up to get notified when there's something new on the Venetoclax in Myeloma with Bortezomib: Clinical Trial page.

Latest updates to the Venetoclax in Myeloma with Bortezomib: Clinical Trial page
- Check2 days agoChange DetectedA site-wide notice was added about NIH websites transitioning terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference0.5%

- Check9 days agoChange DetectedThe footer’s ClinicalTrials.gov site revision changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check16 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check37 days agoChange DetectedA new revision entry (v3.7.0) has been added to the study history and the previous revision (v3.6.6) has been removed, updating the record's version history.SummaryDifference0.1%

- Check94 days agoChange DetectedA new site revision tag 'Revision: v3.6.4' was added, replacing 'Revision: v3.6.3', indicating a minor system update to the page rendering.SummaryDifference0.1%

- Check115 days agoChange DetectedA new revision entry Revision: v3.6.3 was added and the old Revision: v3.6.1 was removed from the study record history. This updates the page's revision metadata without altering core content or functionality.SummaryDifference0.1%

Stay in the know with updates to Venetoclax in Myeloma with Bortezomib: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax in Myeloma with Bortezomib: Clinical Trial page.